Clinical Report: Initiation of Antibiotic Prophylaxis in Pediatric Patients Diagnosed with Sickle Cell Disease

Overview

This study evaluates the initiation of antibiotic prophylaxis in children with sickle cell disease (SCD) in Georgia, revealing that over 80% receive their first prescription by 3 months of age.

Background

Antibiotic prophylaxis is critical for children with sickle cell disease to prevent severe infections, particularly pneumococcal disease. Understanding the factors influencing timely initiation of prophylaxis is essential for improving health outcomes in this vulnerable population.

Data Highlights

Key Findings

• 63.1% of children received their first antibiotic prophylaxis prescription by 2 months of age.
• 81.8% received their first prescription by 3 months of age.
• 98.9% received their first prescription by 12 months of age.
• Children in rural areas had an 18% lower hazard of receiving prophylaxis by 3 months compared to urban children.
• Rural children experienced a delay of approximately 4 days in receiving prophylaxis prescriptions.
• Lower adherence to ongoing prophylaxis is a significant barrier to long-term compliance.

Clinical Implications

The study identifies significant gaps in ongoing adherence that need to be addressed.

Conclusion

The study highlights the effectiveness of Georgia's newborn screening program in facilitating timely antibiotic prophylaxis for children with SCD.

Related Resources & Content

1. American Academy of Pediatrics, Pediatrics, 2024 -- Health Supervision for Children and Adolescents With Sickle Cell Disease: Clinical Report
2. American Academy of Pediatrics, Pediatrics, 1994 -- Prophylaxis With Oral Penicillin in Children With Sickle Cell Anemia: A Randomized Trial
3. the asco post — ASH/ISTH Create Guidelines for Pediatric VTE Prophylaxis
4. Open Forum Infectious Diseases — Assessing the Effectiveness and Economic Impact of Antibiotic Allergy Testing in Pediatric Solid Organ Transplant Recipients
5. Open Forum Infectious Diseases — Efficacy of Levofloxacin Prophylaxis in Preventing Infectious Complications and Mortality in Pediatric and Young Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
6. Infection — Impact of an antimicrobial stewardship intervention on carbapenem use in children with cancer
7. ASH/ISTH Create Guidelines for Pediatric VTE Prophylaxis
8. Assessing the Effectiveness and Economic Impact of Antibiotic Allergy Testing in Pediatric Solid Organ Transplant Recipients
9. Efficacy of Levofloxacin Prophylaxis in Preventing Infectious Complications and Mortality in Pediatric and Young Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
10. Health Supervision for Children and Adolescents With Sickle Cell Disease: Clinical Report | Pediatrics | American Academy of Pediatrics
11. Prophylaxis With Oral Penicillin in Children With Sickle Cell Anemia: A Randomized Trial | Pediatrics | American Academy of Pediatrics
12. National Quality Indicators in Pediatric Sickle Cell Anemia | Pediatrics | American Academy of Pediatrics